ClinicalTrials.govpublic full text
Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours
advanced solid tumours, breast cancer, head and neck cancer, cervix cancer, prostate cancer, durvalumab, tremelimumab, metronomic vinorelbine, high mutational load malignancies, immunotherapy, early phase, combination study
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 854029
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.